0.35
0.35 (0%)
As of Feb 14, 2025
Scilex Holding Co [SCLX]
Source:
Company Overview
We are a Cayman Islands company incorporated on February 21, 2020 as an exempted company with limited liability for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the Business Combination). Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region.
| Country | United States |
| Headquarters | palo alto, california |
| Phone Number | (650) 516-4310 |
| Industry | |
| CEO | Jaisim Shah |
| Website | www.clinicaltrials.gov |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $14.4 |
| Operating Profit | $-19.9 |
| Net Income | $-4.4 |
| Net Cash | $3.4 |
Profit Ratios
| Gross Margin | $10.7 |
| Operating Margin | -138 |
| Profit as % of Revenues | -243.1% |
| Profit as % of Assets | -4.4% |
| Profit as % of Stockholder Equity | 2.1% |
Management Effectiveness
| Return on Equity | 2.1% |
| Return on Assets | -4.4% |
| Turnover Ratio | 14.3% |
| EBITA | $-18.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $100.4 |
| Total Liabilities | $311.7 |
| Operating Cash Flow | $16.8 |
| Investing Cash Flow | $-2.5 |
| Financing Cash Flow | $-10.9 |
